S

Summit Therapeutics
D

SMMT

18.990
USD
0.56
(3.04%)
Market Closed
Volume
32,144
EPS
-0
Div Yield
-
P/E
-83
Market Cap
14,004,140,293
OverviewSignalsIdeasNews
Related Instruments
    A
    ACOR
    -0.26810
    (-30.48%)
    0.61160 USD
    A
    ACRX
    0
    (0%)
    0.000000 USD
    C
    CDXS
    0.13000
    (3.46%)
    3.88500 USD
    D
    DARE
    -0.37000
    (-10.42%)
    3.18000 USD
    E
    ENTX
    0.01000
    (0.57%)
    1.78000 USD
    J
    JAGX
    -0.08040
    (-7.73%)
    0.95960 USD
    M
    MDWD
    -0.360
    (-2.20%)
    16.000 USD
    N
    NNVC
    -0.11000
    (-8.27%)
    1.22000 USD
    O
    OGEN
    -0.01520
    (-4.54%)
    0.31990 USD
    O
    ONTX
    0
    (0%)
    0.000000 USD
    More
News

Title: Summit Therapeutics

Sector: Healthcare
Industry: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.